http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-S86598-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4c6a2eb66d07fad39d708e5a36c9350 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2014-12-16^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7903cceec74ec596e60d5824e6cca45e |
| publicationDate | 2015-11-18^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-S86598-B2 |
| titleOfInvention | An injectable antibody preparation for use in treating or reducing the risk of atopic dermatitis or asthma |
| abstract | An injectable preparation comprising an antibody or antibody fragment for use in a method of treating or reducing the risk of atopic dermatitis or asthma in humans is described. The antibody or antibody fragment of the preparation specifically binds to a human IL4Ra protein that comprises a selected mutation. The antibody or antibody fragment comprises a VH domain derived from the recombination of a human VH segment, a human D gene segment and a human JH segment, the human VH segment of which encodes a specific framework 1 of SEQ ID NO: 40. The human may either comprise a VH gene segment encoding the framework 1, or express VH domains that comprise the framework 1. The human further comprises a nucleotide sequence encoding said IL4Ra protein comprising said selected mutation. |
| priorityDate | 2014-08-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 867 of 867.